Apyx Medical
APYX
19 hedge funds and large institutions have $2.7M invested in Apyx Medical in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 2 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
0% more funds holding
Funds holding: 19 → 19 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
5% less capital invested
Capital invested by funds: $2.84M → $2.7M (-$134K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
+$115K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.4K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$9.91K |
| 4 |
U
UBS
Zurich,
Switzerland
|
+$3.43K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.19K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$111K |
| 2 |
Renaissance Technologies
New York
|
-$25.4K |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$6.52K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$86 |
APYX Hedge Fund Activity: Q3 2013 in Review
19 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q3 2013, worth a combined $2.7M — down 4.7% from $2.84M a quarter earlier.
Fund positioning in APYX was balanced in Q3 2013: 2 funds opened new positions, 2 closed out, 4 added to existing stakes and 3 trimmed.
The largest buyer was Creative Planning, opening a new position worth an estimated $115K. The largest seller was Guggenheim Capital, exiting entirely with an estimated $111K sold.
- 19 institutional investors held Apyx Medical (APYX) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $2.7M of Apyx Medical stock for Q3 2013, down 4.7% quarter-over-quarter.
- 2 funds opened new Apyx Medical positions in Q3 2013 and 2 closed out, a net change of 0 holders.
- The largest Apyx Medical buyer in Q3 2013 was Creative Planning, an estimated $115K added.
- The largest Apyx Medical seller in Q3 2013 was Guggenheim Capital, an estimated $111K sold.
Based on aggregated 13F filings for Q3 2013.